Procedure:   health assessment


Select table page: First Prev Next Last
    Access protocols via the Procedure column.
   FILTER RESULTS BY:
Data set Clear All
Procedure / Protocol Clear All
Drug or Challenge Clear All
Panel Clear All
Sex Clear All
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Boon1 46921 health assessment influenza A (H5N1) virus survival   [d]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Boon1 46931 health assessment influenza A (H5N1) virus susceptibility to viral infection   [designation]     dosage group:    low    medium    high inbred 18 f 6-9wks N=11 2011
    Bopp1 36401 health assessment Plasmodium berghei survival, post-infection   [d]  survival inbred 31 both 8-12wks N=4 2010
    Bopp1 36402 health assessment Plasmodium berghei terminal body temperature, post-infection   [°C]  body_temp inbred 31 both 8-12wks N=4 2010
    Bopp1 36403 health assessment Plasmodium berghei percentage of parasite-infected erythrocytes in blood   [%]  parasitemia inbred 31 both 8-12wks N=4 2010
    Bopp1 36404 health assessment Plasmodium berghei percentage of parasites in brain relative to all organs tested   [%]  luciferase_brain inbred 26 both 8-12wks N=2 2010
    Bopp1 36405 health assessment Plasmodium berghei percentage of parasites in spleen relative to all organs tested   [%]  luciferase_spleen inbred 26 both 8-12wks N=2 2010
    Bopp1 36406 health assessment Plasmodium berghei percentage of parasites in lungs relative to all organs tested   [%]  luciferase_lungs inbred 26 both 8-12wks N=2 2010
    Bopp1 36407 health assessment Plasmodium berghei percentage of parasites in liver relative to all organs tested   [%]  luciferase_liver inbred 26 both 8-12wks N=2 2010
Clemens1 10601 health assessment ultraviolet light UV-induced immunosuppression of contact hypersensitivity   [%]  suppression QTL population both 9-30wks N=67 2000
    Cowell1 49004 health assessment Staphylococcus aureus median survival time (max time = 104 h)   [h]  median_survival inbred 13 f 8wks N=11 2012
    Cowell1 49005 health assessment Staphylococcus aureus percent survival (max time = 104 h)   [%]  pct_survival inbred 13 f 8wks N=11 2012
Davidson1 19201 health assessment (none) 0=exencephaly, 1=normal   [score]  Exencephaly QTL population both embryo N=94 2007
Davidson1 19202 health assessment (none) 1=exencephaly, 0=normal   [score]  Exen2 QTL population both embryo N=94 2007
Farmer1 11327 health assessment (none) diarrhea grade   [score]  Diarrhea QTL population both 6wks N=206 2001
    Ferris1 47603 health assessment influenza A (H1N1) virus clinical score, day 4 post-infection (score 0-4)   [score]  clinical_score CC pre w/CC8 161 f 8-16wks N=1 2012
    Ferris1 47605 health assessment influenza A (H1N1) virus susceptibility to viral infection index (0=susceptible; 1= resistant)   [score]  susceptibility_index CC pre w/CC8 161 f 8-16wks N=1 2012
    Gros2 49302 health assessment Plasmodium chabaudi percent survival post-infection (max=21d)   [%]  survival inbred 22 both 8-10wks N=5 2012
    Gros2 49303 health assessment Plasmodium chabaudi response to infection (0=susceptible, 0.5=intermediate, 1=resistant)   [designation]  resistance inbred 22 both 8-10wks N=5 2012
    Haston1 48801 health assessment radiation  18 Gy number of days in the absence of respiratory distress   [d]  survival inbred 20 both 15-36wks N=7 2012
Leiter2 24001 health assessment (none) age of diabetes onset (dash = no diabetes)   [wks]  Onset QTL population f 14-40wks N=310 2009
Leiter2 24002 health assessment (none) 1 = diabetes, 0 = no diabetes   [score]  DB1_0 QTL population f 14-40wks N=310 2009
    Sandell1 49801 health assessment (none) ear cartilage wound healing 30d post-injury   [mm]  ear LGXSM w/par 13 both 10wks N=7 2012
    Schauwecker1 47701 health assessment pilocarpine pilocarpine dose required to induce status epilepticus (mg/kg body weight)   [mg/kg]  ED100 inbred 8 m 8-10wks N=4 2012
    Schauwecker1 47702 health assessment pilocarpine latency to onset of stage 4 status epilepticus seizures   [min]  latency inbred 8 m 8-10wks N=4 2012
    Schauwecker1 47703 health assessment pilocarpine duration of stage 4 status epilepticus seizures   [min]  duration inbred 8 m 8-10wks N=4 2012
    Schauwecker1 47704 health assessment pilocarpine status epilepticus seizure mortality (0=died; 1=survived)   [designation]  survival inbred 11 m 8-10wks N=18 2012
    Schughart1 39305 health assessment influenza A (H1N1) virus susceptibility to viral infection
(0=susceptible; 1=resistant)   [designation]
 susceptibility
inbred 9 both 10-12wks N=11 2009
    Schughart2 49606 health assessment influenza A (H1N1) virus survival, post-infection (in days)   [d]  survival_days BXD w/par 56 f 9-18wks N=6 2012
    Schughart2 49607 health assessment influenza A (H1N1) virus susceptibility to viral infection
(0=susceptible; 1=resistant)   [designation]
 susceptibility
BXD w/par 56 f 9-18wks N=6 2012
    Schughart3 57181 health assessment influenza A (H3N2) virus survival, post-infection   [d]     10 FFU group    2000 FFU group    200000 FFU group inbred w/CC8 8 both 7-13wks N=11 2013
    Schughart3 57191 health assessment influenza A (H3N2) virus susceptibility to viral infection (0=resistant, 1=susceptible), mortality rate   [score]     10 FFU group    2000 FFU group    200000 FFU group inbred w/CC8 8 both 7-13wks N=11 2013
    All boxes             To see more rows use the paging control at top.